- Q1 2024 OncoCyte Corp Earnings Call TranscriptMay 15, 2024Earnings
- Q4 2023 OncoCyte Corp Earnings Call TranscriptApr 12, 2024Earnings
- Q3 2023 OncoCyte Corp Earnings Call TranscriptNov 09, 2023€3.12Earnings
- Q2 2023 OncoCyte Corp Earnings Call TranscriptAug 10, 2023€3.12Earnings
- OncoCyte Corp Extraordinary Shareholders Meeting TranscriptJul 24, 2023
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 23, 2023
- Q1 2023 OncoCyte Corp Earnings Call TranscriptMay 11, 2023€4.8 (+10.09%)Earnings
- Q4 2022 OncoCyte Corp Earnings Call TranscriptApr 03, 2023€5.2 (+11.11%)Earnings
- Q3 2022 OncoCyte Corp Earnings Call TranscriptNov 10, 2022€12 (-2.44%)Earnings
- OncoCyte Corp at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 11, 2022
- Q2 2022 OncoCyte Corp Earnings Call TranscriptAug 10, 2022€16.6 (-9.29%)Earnings
- OncoCyte Corp DetermalO™ and Tumor Microenvironment in Clinical Practice Key Opinion Leader TranscriptJun 28, 2022
- Q1 2022 OncoCyte Corp Earnings Call TranscriptMay 11, 2022€21.6 (+4.85%)Earnings
- Q4 2021 OncoCyte Corp Earnings Call TranscriptMar 10, 2022€23.2 (-7.20%)Earnings
- OncoCyte Corp to Discuss Development and Co-Marketing Agreement with Thermo Fisher Scientific Inc Call TranscriptJan 18, 2022
- OncoCyte Corp Investor and Analyst Day TranscriptDec 14, 2021
- Q3 2021 OncoCyte Corp Earnings Call TranscriptNov 09, 2021€60 (+4.90%)Earnings
- OncoCyte Corp Key Opinion Leader Presentation Part 2: DetermaIO™ in Triple-Negative Breast Cancer TranscriptSep 28, 2021
- OncoCyte Corp Key Opinion Leader Presentation Part 1: Transplant Rejection Testing TranscriptSep 22, 2021
- Q2 2021 OncoCyte Corp Earnings Call TranscriptAug 10, 2021€83.6 (+0.48%)Earnings
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 24, 2021
- Q1 2021 OncoCyte Corp Earnings Call TranscriptMay 17, 2021€63.6Earnings
- OncoCyte Corp DetermaIO™ Data KOL Webinar TranscriptApr 19, 2021
- Q4 2020 OncoCyte Corp Earnings Call TranscriptMar 16, 2021€82.4 (+4.04%)Earnings
- Q3 2020 OncoCyte Corp Earnings Call TranscriptNov 12, 2020€29.8 (+4.93%)Earnings
- OncoCyte Corp - EGFR And Molecular Risk Stratification In Early-Stage NSCLC TranscriptOct 22, 2020
- OncoCyte Corporation - Special Call TranscriptAug 19, 2020
- Q2 2020 OncoCyte Corp Earnings Call TranscriptJul 29, 2020€23.6 (+1.72%)Earnings
- OncoCyte Corp Announces Completion Of Determadx™ Clinical Validation Study TranscriptJun 29, 2020
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 17, 2020
- Q1 2020 OncoCyte Corp Earnings Call TranscriptMay 12, 2020€52.4 (+0.77%)Earnings
- Q4 2019 OncoCyte Corp Earnings Call TranscriptMar 25, 2020€37 (+1.65%)Earnings
- OncoCyte Corp to Acquire Insight Genetics Inc - Conference Call TranscriptJan 10, 2020
- Q3 2019 OncoCyte Corp Earnings Call TranscriptNov 14, 2019€29 (-3.97%)Earnings
- Q2 2019 OncoCyte Corp Earnings Call TranscriptAug 14, 2019€36.92 (+5.23%)Earnings
OncoCyte Corp Annual Shareholders Meeting Transcript
Hello, and welcome to the 2023 OncoCyte Corporation Annual Meeting of Shareholders. Please note that this meeting is being recorded. (Operator Instructions) It is my pleasure to now turn the meeting over to Andrew Arno. Mr. Arno, the floor is yours.
Good morning. On behalf of OncoCyte Corporation, I would like to thank you for participating in our 2023 Annual Meeting of Shareholders. I am Andrew Arno, Chairman of the Board of Directors. In accordance with the company's bylaws, I will be presiding over this annual meeting.
We are hosting the meeting virtually, which allows our shareholders to attend and listen to the meeting live, submit questions and vote their shares electronically. As Chairman of this meeting, I have set the agenda, which you should be able to see on your screen. I have also set certain meeting procedures and rules of conduct, which you can access by clicking on the documents icon on the top left side of your screen.
At this time, I'd like to introduce our President
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)